Literature DB >> 9242312

Predictors of a fatal outcome following childhood cerebral malaria.

S Jaffar1, M B Van Hensbroek, A Palmer, G Schneider, B Greenwood.   

Abstract

Despite prompt treatment with an effective anti-malarial drug, cerebral malaria still has a mortality of 20-30%. To identify factors that may contribute to this high fatality rate, we have studied the relationship between clinical and laboratory features and a fatal outcome in 624 Gambian children with strictly defined cerebral malaria. One hundred twenty-four children (21.5%) died. Three-quarters of the deaths occurred within 24 hr of admission. Multiple logistic regression analysis showed that a cold periphery (odds ratio [OR] = 2.7), a deep coma (OR = 2.0), and hypoglycemia (OR = 4.1) were the clinical signs and laboratory parameters that predicted death most strongly. More than 90% of the children who died had at least one of these conditions. Also, children with elevated urea levels on admission or those who experienced multiple episodes of hypoglycemia or multiple convulsions subsequently were more likely to die. A combination of clinical and laboratory abnormalities can identify a group of children with cerebral malaria who are most at risk of dying, who require intensive care and who are candidates for new forms of therapy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9242312     DOI: 10.4269/ajtmh.1997.57.20

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  33 in total

Review 1.  Artemisinin derivatives versus quinine for cerebral malaria in African children: a systematic review.

Authors:  Hmwe Hmwe Kyu; Eduardo Fernández
Journal:  Bull World Health Organ       Date:  2009-07-30       Impact factor: 9.408

Review 2.  Hypoglycemia in critically ill children.

Authors:  E Vincent S Faustino; Eliotte L Hirshberg; Clifford W Bogue
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

3.  Risk factors for persisting neurological and cognitive impairments following cerebral malaria.

Authors:  R Idro; J A Carter; G Fegan; B G R Neville; C R J C Newton
Journal:  Arch Dis Child       Date:  2005-12-02       Impact factor: 3.791

4.  Artemether for severe malaria.

Authors:  Ekpereonne B Esu; Emmanuel E Effa; Oko N Opie; Martin M Meremikwu
Journal:  Cochrane Database Syst Rev       Date:  2019-06-18

5.  Electroencephalographic and clinical features of cerebral malaria.

Authors:  J Crawley; S Smith; P Muthinji; K Marsh; F Kirkham
Journal:  Arch Dis Child       Date:  2001-03       Impact factor: 3.791

6.  Effect of vitamin A adjunct therapy for cerebral malaria in children admitted to Mulago hospital: a randomized controlled trial.

Authors:  J Mwanga-Amumpaire; G Ndeezi; J K Tumwine
Journal:  Afr Health Sci       Date:  2012-06       Impact factor: 0.927

7.  Evidence for multiple pathologic and protective mechanisms of murine cerebral malaria.

Authors:  V M Jennings; A A Lal; R L Hunter
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Severe anaemia in childhood cerebral malaria is associated with profound coma.

Authors:  Richard Idro
Journal:  Afr Health Sci       Date:  2003-04       Impact factor: 0.927

Review 9.  High first dose quinine regimen for treating severe malaria.

Authors:  A Lesi; M Meremikwu
Journal:  Cochrane Database Syst Rev       Date:  2004

10.  Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children.

Authors:  Fiona E Lovegrove; Noppadon Tangpukdee; Robert O Opoka; Erin I Lafferty; Nimerta Rajwans; Michael Hawkes; Srivicha Krudsood; Sornchai Looareesuwan; Chandy C John; W Conrad Liles; Kevin C Kain
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.